Laboratorio Echevarne   Report issue

For profit Phase 4
Founded: Barcelona Spain (1958)
Status: No NME R&D (1958)

Organization Overview

First Clinical Trial
2014
NCT02148718
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Laboratorio Echevarne

Active Ingredients

Drugs in Phase 4 Trials (3)

adalimumab (humira) (1 trial)

melatonin (2 trials)

zn2+ (1 trial)

Drugs in Other Trials (3)

isomaltose (1 trial)

magnesium stearate (1 trial)

zinc (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Crohn Disease (Phase 4)

Encephalomyelitis (Phase 4)

Fatigue (Phase 4)

Fatigue Syndrome, Chronic (Phase 4)

Myalgia (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6